Torbenson MS - Search Results

1

Chronic intermittent hypoxia predisposes to liver injury.

Savransky V, Nanayakkara A, Vivero A, Li J, Bevans S, Smith PL, Torbenson MS, Polotsky VY. Savransky V, et al. Among authors: torbenson ms. Hepatology. 2007 Apr;45(4):1007-13. doi: 10.1002/hep.21593. Hepatology. 2007. PMID: 17393512

2

Severity and correlates of liver disease in hepatitis C virus-infected injection drug users.

Rai R, Wilson LE, Astemborski J, Anania F, Torbenson M, Spoler C, Vlahov D, Strathdee SA, Boitnott J, Nelson KE, Thomas DL. Rai R, et al. Hepatology. 2002 May;35(5):1247-55. doi: 10.1053/jhep.2002.33151. Hepatology. 2002. PMID: 11981775

3

Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review.

Gebo KA, Chander G, Jenckes MW, Ghanem KG, Herlong HF, Torbenson MS, El-Kamary SS, Bass EB. Gebo KA, et al. Among authors: torbenson ms. Hepatology. 2002 Nov;36(5 Suppl 1):S84-92. doi: 10.1053/jhep.2002.36817. Hepatology. 2002. PMID: 12407580 Review.

4

Treatment of chronic hepatitis C: a systematic review.

Chander G, Sulkowski MS, Jenckes MW, Torbenson MS, Herlong HF, Bass EB, Gebo KA. Chander G, et al. Among authors: torbenson ms. Hepatology. 2002 Nov;36(5 Suppl 1):S135-44. doi: 10.1053/jhep.2002.37146. Hepatology. 2002. PMID: 12407587 Review.

5

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, Chander G, Ghanem KG, El-Kamary SS, Sulkowski M, Bass EB. Gebo KA, et al. Among authors: torbenson ms. Hepatology. 2002 Nov;36(5 Suppl 1):S161-72. doi: 10.1053/jhep.2002.36989. Hepatology. 2002. PMID: 12407590 Review.

6

Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury.

Oben JA, Roskams T, Yang S, Lin H, Sinelli N, Li Z, Torbenson M, Huang J, Guarino P, Kafrouni M, Diehl AM. Oben JA, et al. Hepatology. 2003 Sep;38(3):664-73. doi: 10.1053/jhep.2003.50371. Hepatology. 2003. PMID: 12939593

7

High prevalence of occult hepatitis B in Baltimore injection drug users.

Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. Torbenson M, et al. Hepatology. 2004 Jan;39(1):51-7. doi: 10.1002/hep.20025. Hepatology. 2004. PMID: 14752822

8

The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.

Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, Moore RD, Sulkowski MS. Mehta SH, et al. Among authors: torbenson m. Hepatology. 2005 Jan;41(1):123-31. doi: 10.1002/hep.20541. Hepatology. 2005. PMID: 15619237

9

Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network. Kleiner DE, et al. Among authors: torbenson ms. Hepatology. 2005 Jun;41(6):1313-21. doi: 10.1002/hep.20701. Hepatology. 2005. PMID: 15915461

10

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

Wilson LE, Torbenson M, Astemborski J, Faruki H, Spoler C, Rai R, Mehta S, Kirk GD, Nelson K, Afdhal N, Thomas DL. Wilson LE, et al. Hepatology. 2006 Apr;43(4):788-95. doi: 10.1002/hep.21091. Hepatology. 2006. PMID: 16557548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

318 results

Search Page